miR-143 and miR-145 synergistically regulate ERBB3 to suppress cell proliferation and invasion in breast cancer
暂无分享,去创建一个
Hongwei Liang | Xi Chen | Ting Deng | Rui Liu | Xin Yan | Baorui Liu | Yi Ba | Ke Zen | Chen-Yu Zhang | Weixu Chen | Suyang Zhang | Minghui Liu | Xiujuan Gao | Yanqing Liu | Chihao Zhao | Xueliang Wang | Nan Wang | Jialu Li
[1] C. Croce,et al. MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.
[2] W. Cho. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. , 2010, The international journal of biochemistry & cell biology.
[3] K. Nephew,et al. EGFR signaling in breast cancer: bad to the bone. , 2010, Seminars in cell & developmental biology.
[4] A. Jemal,et al. Global Cancer Statistics , 2011 .
[5] Jacques Ferlay,et al. Estimating the world cancer burden: Globocan 2000 , 2001, International journal of cancer.
[6] Lin He,et al. MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature Reviews Genetics.
[7] L. Anderson,et al. The ERBB3 receptor in cancer and cancer gene therapy , 2008, Cancer Gene Therapy.
[8] W. Cho,et al. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation. , 2009, European journal of cancer.
[9] C. Croce,et al. MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.
[10] J. Segall,et al. ErbB3-dependent motility and intravasation in breast cancer metastasis. , 2006, Cancer research.
[11] Ravi Jain,et al. MicroRNA-143 Regulates Adipocyte Differentiation* , 2004, Journal of Biological Chemistry.
[12] Jing Li,et al. miR-145 inhibits breast cancer cell growth through RTKN. , 2009, International journal of oncology.
[13] F. Slack,et al. Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.
[14] Kathryn A. O’Donnell,et al. Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model , 2009, Cell.
[15] D. Wheeler,et al. Mechanisms of resistance to HER family targeting antibodies. , 2010, Experimental cell research.
[16] C. Burge,et al. Prediction of Mammalian MicroRNA Targets , 2003, Cell.
[17] D. Stern. ERBB3/HER3 and ERBB2/HER2 Duet in Mammary Development and Breast Cancer , 2008, Journal of Mammary Gland Biology and Neoplasia.
[18] X. Chen,et al. Role of miR-143 targeting KRAS in colorectal tumorigenesis , 2009, Oncogene.
[19] K. Gunsalus,et al. Combinatorial microRNA target predictions , 2005, Nature Genetics.
[20] N. Wu,et al. MicroRNA-145 Function as a Cell Growth Repressor by Directly Targeting c-Myc in Human Ovarian Cancer , 2014, Technology in cancer research & treatment.
[21] N. Guo,et al. MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer. , 2009, Cancer treatment reviews.
[22] N. Rajewsky,et al. Silencing of microRNAs in vivo with ‘antagomirs’ , 2005, Nature.
[23] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[24] Anton J. Enright,et al. Human MicroRNA Targets , 2004, PLoS biology.
[25] A. Hamburger. The Role of ErbB3 and its Binding Partners in Breast Cancer Progression and Resistance to Hormone and Tyrosine Kinase Directed Therapies , 2008, Journal of Mammary Gland Biology and Neoplasia.
[26] V. Ambros. The functions of animal microRNAs , 2004, Nature.
[27] Edith A Perez,et al. MicroRNA signatures: clinical biomarkers for the diagnosis and treatment of breast cancer. , 2011, Trends in molecular medicine.
[28] I. Pogribny,et al. MicroRNA-mediated drug resistance in breast cancer , 2011, Clinical Epigenetics.
[29] Michael Z Michael,et al. Reduced accumulation of specific microRNAs in colorectal neoplasia. , 2003, Molecular cancer research : MCR.
[30] R. Mancini,et al. Novel anti‐ErbB3 monoclonal antibodies show therapeutic efficacy in xenografted and spontaneous mouse tumors , 2012, Journal of cellular physiology.
[31] Y. Mo,et al. MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. , 2010, Cancer research.
[32] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.